(20371917), S. K. (2025). Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells.
Chicago-čujuhus (17. p.)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
MLA-čujuhus (9. p.)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.